Searchable abstracts of presentations at key conferences in endocrinology

ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts

Published by BioScientifica

Previous issue | Volume 70 | ECE2020 | Next issue

22nd European Congress of Endocrinology

Online
05 Sept 2020 - 09 Sept 2020

Card image cap

Europe's leading endocrinology congress showcasing the very best in the study and treatment of endocrine disorders.

Audio ePoster Presentations

Pituitary and Neuroendocrinology

Previous section
General Endocrinology

Table of contents

Next section
Reproductive and Developmental Endocrinology

ea0070aep560 | Pituitary and Neuroendocrinology

Proliferation index (Ki67) is a powerful predictor of recurrence in pituitary adenoma

ea0070aep561 | Pituitary and Neuroendocrinology

The expression level and binding affinity of glucocorticoid receptors in patients with Cushing’s syndrome

ea0070aep562 | Pituitary and Neuroendocrinology

Treatment of acromegalic osteopathy in the real-life clinical practice: The baac (bone active drugs in acromegaly) multicenter study

ea0070aep563 | Pituitary and Neuroendocrinology

Macrophages involvement in neuroendocrine tumor behaviour and progression

ea0070aep564 | Pituitary and Neuroendocrinology

Cushing’s syndrome & disease: Why does it take so long to diagnose; is the interdisciplinary medical team aware of the signs and symptoms; what are the consequences?

ea0070aep565 | Pituitary and Neuroendocrinology

Hypercortisolism-related molecular signature: Results from whole blood methylome analysis

ea0070aep566 | Pituitary and Neuroendocrinology

Plasma microRNA levels in patients with active acromegaly

ea0070aep567 | Pituitary and Neuroendocrinology

Multigene liquid biopsy (NETest) is diagnostic of pancreatic and small bowel neuroendocrine tumours and correlates with imaging

ea0070aep568 | Pituitary and Neuroendocrinology

Modelling neuroendocrine tumours using 3 dimensional cell culturing

ea0070aep569 | Pituitary and Neuroendocrinology

Difference in plasma miRNA levels in inferior petrosal sinus samples from patients with ACTH-dependent Cushing’s syndrome as assessed by next-generation sequencing (NGS).

ea0070aep570 | Pituitary and Neuroendocrinology

Challenges in the management of pituitary involvement in granulomatosis with Polyangitis (GPA): 2 cases managed at Imperial college healthcare trust

ea0070aep571 | Pituitary and Neuroendocrinology

Deletion of chromosome 1q24-1q32 and combined pituitary hormone deficiency type 4: Insight into the challenges of genotype-phenotype correlation

ea0070aep572 | Pituitary and Neuroendocrinology

Baseline IGF-I values influence the effect of rhGH therapy on fat mass: Short, medium and long term study on adults with GH deficiency

ea0070aep573 | Pituitary and Neuroendocrinology

The SAGIT instrument: Potential utility in treatment decision-making in acromegaly

ea0070aep574 | Pituitary and Neuroendocrinology

Cushing’s disease: Assessment of MGMT expression in pituitary corticotroph tumors and its relationship to clinical, pathological and ultrastructural parameters

ea0070aep575 | Pituitary and Neuroendocrinology

Temporal trends in craniopharyngioma management and long term endocrine outcomes

ea0070aep576 | Pituitary and Neuroendocrinology

Sustained response to treatment with oral octreotide capsules: Results from the phase 3, randomized, double blind, placebo-controlled optimal study

ea0070aep577 | Pituitary and Neuroendocrinology

Biochemical control of most patients reverting to injectable long-acting somatostatin receptor ligands is achieved after one dose: Results from the phase 3, randomized, double blind, placebo-controlled optimal study

ea0070aep578 | Pituitary and Neuroendocrinology

Association between sagittal spine imbalance and radiological vertebral fractures in acromegaly: Does it reflect a pathophysiological link?

ea0070aep579 | Pituitary and Neuroendocrinology

Once-weekly somapacitan in japanese adults with growth hormone deficiency was well tolerated, with similar efficacy to daily growth hormone: A randomised trial

ea0070aep580 | Pituitary and Neuroendocrinology

Real life efficiency of pegvisomant therapy in acromegaly

ea0070aep581 | Pituitary and Neuroendocrinology

Sheehan like syndrome in males: A case series of three patients developing pituitary infarction following hypotension

ea0070aep582 | Pituitary and Neuroendocrinology

An asynchronous double growth hormone secreting pituitary adenoma ofa different proliferative potential – a case report

ea0070aep583 | Pituitary and Neuroendocrinology

Not just another headache – a rare case of recurrent pituitary collection

ea0070aep584 | Pituitary and Neuroendocrinology

A novel mechanism regulating dopamine receptor type 2 (DRD2) signal transduction in PRL- and ACTH-secreting pituitary tumoral cells: The role of cAMP/PKA-induced filamin A (FLNA) phosphorylation in the control of responsiveness to DRD2 agonist

ea0070aep585 | Pituitary and Neuroendocrinology

Kisspeptin-54 accurately identifies hypothalamic dysfunction in men with congenital hypogonadotropic hypogonadism

ea0070aep586 | Pituitary and Neuroendocrinology

Growth hormone-releasing hormone (GHRH) promotes survival and proliferation of neural stem cells and reduces amyloid-β-induced toxicity

ea0070aep587 | Pituitary and Neuroendocrinology

Pancreatic neuroendocrine tumour with suspected extrarenal secretion of 1,25-dihydroxyvitamin D3

ea0070aep588 | Pituitary and Neuroendocrinology

New advances in the diagnosis of gonadotroph tumours

ea0070aep589 | Pituitary and Neuroendocrinology

The cushing’s collaborative patient survey results

ea0070aep590 | Pituitary and Neuroendocrinology

High-dose corticosteroid treatment of immunotherapy-induced hypophysitis: A multi-centric, restrospective analysis

ea0070aep591 | Pituitary and Neuroendocrinology

Assessment of hypercoagulability in patients with cushing syndrome before and after surgical cure

ea0070aep592 | Pituitary and Neuroendocrinology

Morphometric vertebral fractures are highly prevalent in patients with non-functioning pituitary adenoma and related to older age and hypopituitarism

ea0070aep593 | Pituitary and Neuroendocrinology

Course of serum potassium levels during the hypertonic saline infusion test for diagnosis of diabetes insipidus

ea0070aep594 | Pituitary and Neuroendocrinology

Concordant testing results in differential diagnosis in ACTH-dependent cushing’s syndrome: A retrospective study of high dose dexamethasone suppression test (HDDST) and DDAVP stimulation test

ea0070aep595 | Pituitary and Neuroendocrinology

Gallium-68 -DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas

ea0070aep596 | Pituitary and Neuroendocrinology

Efficacy and safety of long-acting pasireotide (LA-PAS) in patients with uncontrolled acromegaly: Results from the prospective cohort of european observational acronis study

ea0070aep597 | Pituitary and Neuroendocrinology

High usage of drugs for neuropsychiatric morbidity in patients with Cushing´s disease before diagnosis and at 5–10 years follow-up – a nationwide study

ea0070aep598 | Pituitary and Neuroendocrinology

The importance of DHEA-S levels in cushing’s syndrome; is there a cut-off value in the differential diagnosis?

ea0070aep599 | Pituitary and Neuroendocrinology

Midparental height is an important predictive parameter in a late diagnosis of acromegaly and gigantism in adults. Single centre, pilot study

ea0070aep600 | Pituitary and Neuroendocrinology

Phenotypic differences between patients with familial pituitary neuroendocrine tumours due to MEN1 or AIP mutations

ea0070aep601 | Pituitary and Neuroendocrinology

A case of wolfram syndrome with primary hypogonadism

ea0070aep602 | Pituitary and Neuroendocrinology

Effect of silibinin on acth synthesis and secretion in human adenomatous corticotropes in vitro

ea0070aep603 | Pituitary and Neuroendocrinology

TGF-β increases caspase 3 activation and migration in bronchial carcinoids

ea0070aep604 | Pituitary and Neuroendocrinology

Salivary cortisol and cortisone – Effects of liquorice and blood contamination

ea0070aep605 | Pituitary and Neuroendocrinology

An education programme for patients with pituitary tumours and their relatives; preliminary results

ea0070aep606 | Pituitary and Neuroendocrinology

Clinical picture and MRI findings in patients with hypophysitis – a single-centre experience

ea0070aep607 | Pituitary and Neuroendocrinology

Data mining analyses for precision medicine in acromegaly

ea0070aep608 | Pituitary and Neuroendocrinology

Metabolism of glucose in patients with acromegaly treated with Pegvisomant and/or Pasireotide LAR after resistance to first generation somatostatin receptor ligands

ea0070aep609 | Pituitary and Neuroendocrinology

Biliary stone disease in acromegaly under somatostatinanalogues: A longterm safety study

ea0070aep610 | Pituitary and Neuroendocrinology

Importance of sexual function assessment in multidimensional evaluation of AGHD patients: Baseline results from the management of adult growth hormone deficiency (MAGHD) study

ea0070aep611 | Pituitary and Neuroendocrinology

Effects of different therapeutic approaches on cardiovascular risk in patients with acromegaly: Results of a multicentric study

ea0070aep612 | Pituitary and Neuroendocrinology

IGF-I variability and its association with demographic and clinical characteristics in patients with acromegaly treated with injectable somatostatin receptor ligands (SRLs); results from OPTIMAL, an international prospective phase 3 study

ea0070aep613 | Pituitary and Neuroendocrinology

Analysis of adverse events in adult patients with acromegaly receiving oral octreotide capsules: Results from the phase 3, randomized, double-blind, placebo-controlled optimal study

ea0070aep614 | Pituitary and Neuroendocrinology

The effects of silent pituitary adenomas on pregnancy

ea0070aep615 | Pituitary and Neuroendocrinology

Cushing’s syndrome negatively affects socio-economic variables many years before the diagnosis: A nationwide registry-based cohort study

ea0070aep616 | Pituitary and Neuroendocrinology

Prevalence, predictors and outcomes of acute, life-threatening and perioperative complications in cushing’s syndrome

ea0070aep617 | Pituitary and Neuroendocrinology

SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors

ea0070aep618 | Pituitary and Neuroendocrinology

Efficacy, safety and pitfalls of glucocorticoid therapy for patients with autoimmune hypophysitis

ea0070aep619 | Pituitary and Neuroendocrinology

Observational study of aetiology, efficacy of treatment and outcomes of hyponatraemia following pituitary surgery in a major neurosurgical centre

ea0070aep620 | Pituitary and Neuroendocrinology

Growth hormone deficiency in childhood acute lymphoblastic leukemia survivors – should systematic stimulation test be performed in all irradiated children?

ea0070aep621 | Pituitary and Neuroendocrinology

9-CIS retinoic acid decreases pomc expression and cell viability in experimental model of ectopic cushing syndrome

ea0070aep622 | Pituitary and Neuroendocrinology

Sporadic neuroendocrine neoplasms in young-adult patients: Differences in natural history, prognosis and treatment compared to adult-elderly patients

ea0070aep623 | Pituitary and Neuroendocrinology

Temporal trends in incidence, evaluation and management of neuroendocrine neoplasms of the appendix-15 years’ experience

ea0070aep624 | Pituitary and Neuroendocrinology

Contribution of NGS in the genetic analysis of neuroendocrine tumors associated with Multiple Endocrine neoplasia type 1 (MEN 1)

ea0070aep625 | Pituitary and Neuroendocrinology

Malignant insulinoma treated with ¹⁷⁷Lu-DOTATATE: Results in the first year post-therapy

ea0070aep626 | Pituitary and Neuroendocrinology

Surgical and survival outcomes of early peptide receptor radionuclide therapy for downstaging locally advanced or oligometastatic pancreatic neuroendocrine neoplasms

ea0070aep627 | Pituitary and Neuroendocrinology

Absolute oral bioavailability and absorption, metabolism, excretion of [14C]-Labeled paltusotine (CRN00808), an orally bioavailable, nonpeptide, selective, somatostatin receptor 2 (sst2) biased agonist for the treatment of acromegaly

ea0070aep628 | Pituitary and Neuroendocrinology

Safety and IGF-1 levels with once daily oral sst2 agonist paltusotine (CRN00808) in acromegaly patients previously treated with peptide long-acting somatostatin receptor ligands: Initial data from the open label ACROBAT Edge phase 2 study

ea0070aep629 | Pituitary and Neuroendocrinology

The time, mode and markers of pituitary function deterioration in patients with PROP1 mutation. Single centre, longitudinal observation

ea0070aep630 | Pituitary and Neuroendocrinology

Clinical presentations of patients with MEN 1 syndrome and its phenocopies

ea0070aep631 | Pituitary and Neuroendocrinology

Functional panhypopituitarism of anorexia

ea0070aep632 | Pituitary and Neuroendocrinology

A case of primary hypophysitis with cavernous sinus infiltration causing an unilateral internal carotid artery occlusion

ea0070aep633 | Pituitary and Neuroendocrinology

ACTH-secreting pituitary tumor with delayed aggressive clinical recurrence – management challenges

ea0070aep634 | Pituitary and Neuroendocrinology

Unusual case of women suffering from aggressive silent thyrotropinoma treated with somatostatin analogues during pregnancy

ea0070aep635 | Pituitary and Neuroendocrinology

Secondary amenorrhea, acute hydrocephalus and syndrome of inappropriate secretion of antidiuretic hormone as first manifestations of neurosarcoidosis

ea0070aep636 | Pituitary and Neuroendocrinology

Complicated endocrinopathy after liver transplantation for unusual diagnosis

ea0070aep637 | Pituitary and Neuroendocrinology

A rare association of hypogonadotropic hypogonadism and GH deficiency in a patient with Addison’s disease

ea0070aep638 | Pituitary and Neuroendocrinology

46XY DSD as initial clinical presentation in a patient with syndromic combined pituitary hormones deficiency

ea0070aep639 | Pituitary and Neuroendocrinology

Clinical and hormonal features of congenital hypopituitarism

ea0070aep640 | Pituitary and Neuroendocrinology

Looking for cyclic cushing’s syndrome

ea0070aep641 | Pituitary and Neuroendocrinology

Medical treatment leading to remission of ectopic cushing’s syndrome

ea0070aep642 | Pituitary and Neuroendocrinology

An uncommon cause of atrial fibrillation

ea0070aep643 | Pituitary and Neuroendocrinology

Osmotic demyelination syndrome in a patient with noonan syndrome and anterior hypopituitarism

ea0070aep644 | Pituitary and Neuroendocrinology

A case of developmental delay by 18q23 deletion syndrome

ea0070aep645 | Pituitary and Neuroendocrinology

Sodium copeptin ratio differentiates patients with and without acute diabetes insipidus post neurosurgery

ea0070aep646 | Pituitary and Neuroendocrinology

Differences in acquired and idiopathic adult-onset growth hormone deficiency

ea0070aep647 | Pituitary and Neuroendocrinology

Evaluation of the of alpha2-adrenergic receptors stimulation effect on copeptin secretion, based on the result of the test with clonidine used in the diagnosis of children with short stature

ea0070aep648 | Pituitary and Neuroendocrinology

Typical carcinoid of the nose: The role of somatostatin agonist following surgery

ea0070aep649 | Pituitary and Neuroendocrinology

Multi-hormonal secretion in a young male with a large cystic pancreatic neuroendocrine neoplasm

ea0070aep650 | Pituitary and Neuroendocrinology

Differentiation of Insulinoma from accessory spleen by 99mTc-labelled heat-denaturated red blood cell scintigraphy

ea0070aep651 | Pituitary and Neuroendocrinology

Predictors of Cushing’s disease remission after transsphenoidal endoscopic surgery

ea0070aep652 | Pituitary and Neuroendocrinology

Acrodat – a useful tool to manage acromegaly patients

ea0070aep653 | Pituitary and Neuroendocrinology

Characterization of pituitary adenomas by immunohistochemistry of pituitary-specific transcription factors and their correlation with hormonal subtypes

ea0070aep654 | Pituitary and Neuroendocrinology

Our experience with lu-dotatate in patients with neuroendocrine tumors in a tertiary hospital

ea0070aep656 | Pituitary and Neuroendocrinology

Characteristics of severe forms of Cushing’s disease compared to milder cases

ea0070aep657 | Pituitary and Neuroendocrinology

The impact of variations in laboratory measurements of IGF-1 and random growth hormone on the classification of acromegaly disease activity status: Lessons from the UK Acromegaly Register Reference Laboratory

ea0070aep658 | Pituitary and Neuroendocrinology

Prevalence of non-alcoholic fatty liver disease in patients with Cushing disease (CD)

ea0070aep659 | Pituitary and Neuroendocrinology

Tumour progression in clinically non-functioning pituitary adenomas- does somatostatin analogue therapy decrease the risk?

ea0070aep660 | Pituitary and Neuroendocrinology

Predictors for remission after transsphenoidal surgery in acromegaly: A dutch multicenter study

ea0070aep661 | Pituitary and Neuroendocrinology

Metyrapone treatment in endogenous Cushing’s syndrome. Results from a prospective multicenter, open-label, phase III/IV study: Prompt

ea0070aep662 | Pituitary and Neuroendocrinology

Predictors of response to medical therapy with pegvisomant and pasireotide lar in SRLs-resistant acromegaly

ea0070aep663 | Pituitary and Neuroendocrinology

Efficacy of monotherapy versus combined GH receptor antagonist therapy in patients with somatostatin receptor analogues resistant acromegaly

ea0070aep664 | Pituitary and Neuroendocrinology

The role of repeated prolactin samples in patients with hyperprolactinaemia

ea0070aep665 | Pituitary and Neuroendocrinology

Assessment of disease control in patients with acromegaly treated with long-acting somatostatin analogs (SMSa) varies according to the time when IGF-I levels are measured during the month following the injection

ea0070aep666 | Pituitary and Neuroendocrinology

Surgical and clinical outcome in elderly patients affected by non-functional pituitary adenoma treated by endoscopic transnasal transsphenoidal surgery: A monocentric study

ea0070aep667 | Pituitary and Neuroendocrinology

Gender differences in airway obstruction in men and women with acromegaly: A longitudinal study

ea0070aep668 | Pituitary and Neuroendocrinology

Withdrawal from long-acting somatostatin receptor ligand injections in adult patients with acromegaly: Results from the phase 3, randomized, double-blind, placebo-controlled optimal study

ea0070aep669 | Pituitary and Neuroendocrinology

Impact of imputation method on efficacy results from the phase 3 optimal study of oral octreotide capsules in adult patients with acromegaly

ea0070aep670 | Pituitary and Neuroendocrinology

Eucaloric very low-carbohydrate ketogenic diet as a new supportive treatment modality for acromegaly?

ea0070aep671 | Pituitary and Neuroendocrinology

To score or not to score? Is Ki-67 analysis worthwhile in pituitary neuroendocrine tumours?

ea0070aep672 | Pituitary and Neuroendocrinology

Giant prolactinomas: Is it possible to stop treatment?

ea0070aep673 | Pituitary and Neuroendocrinology

Development of a local reference range for hypertonic saline-stimulated copeptin

ea0070aep674 | Pituitary and Neuroendocrinology

A key role for conservative treatment in the management of pituitary apoplexy

ea0070aep675 | Pituitary and Neuroendocrinology

Gender dimorphism of intramuscular fatty infiltration and related muscle dysfunction in patients with long-term control of acromegaly

ea0070aep676 | Pituitary and Neuroendocrinology

European Society of Endocrinology audit and multi-country comparison of Adult Growth Hormone Deficiency (AGHD) treatment in clinical practice in Europe and Australia; –how closely are protocols and best practice recommendations followed

ea0070aep677 | Pituitary and Neuroendocrinology

Carpal tunnel syndrome is common in patients with undiagnosed acromegaly – a swedish nationwide study

ea0070aep678 | Pituitary and Neuroendocrinology

Levoketoconazole in the treatment of endogenous Cushing’s syndrome: Extended evaluation phase results of the SONICS study

ea0070aep679 | Pituitary and Neuroendocrinology

Role of NGS in the diagnostic work-up of pituitary tumors and ‘incidental findings’

ea0070aep680 | Pituitary and Neuroendocrinology

fMRI for cognitive evaluation of adult survivors of childhood craniopharyngioma

ea0070aep681 | Pituitary and Neuroendocrinology

Effects of long-term growth hormone replacemente therapy on body composition in adult patients with growth hormone deficiency

ea0070aep682 | Pituitary and Neuroendocrinology

Perception of stature and quality of life in young adult men referred for tall stature during adolescence. Perception of stature and quality of life in young adult men referred for tall stature during adolescence.

ea0070aep683 | Pituitary and Neuroendocrinology

Antitumor effects of growth hormone-releasing hormone (GHRH) antagonists in ACTH- and GH-secreting pituitary neuroendocrine tumor cell lines

ea0070aep684 | Pituitary and Neuroendocrinology

Evaluation of somatostatin and dopamine receptor expression in nonfunctioning pituitary adenomas

ea0070aep685 | Pituitary and Neuroendocrinology

High prevalence of pituitary deficiency after cranial radiation therapy for skull base meningioma: The importance of an annual screening.

ea0070aep686 | Pituitary and Neuroendocrinology

Role of 68ga-dotatoc pet/ct in the management of neuroendocrine tumors

ea0070aep687 | Pituitary and Neuroendocrinology

Endoscopic transsphenoidal pituitary surgery (ETPS) for pituitary tumors: Outcomes and complications

ea0070aep688 | Pituitary and Neuroendocrinology

Do cardiovascular risk factors predispose to pituitary apoplexy?

ea0070aep689 | Pituitary and Neuroendocrinology

Trabecular bone score as a useful tool for assessment of fracture risk in acromegaly

ea0070aep690 | Pituitary and Neuroendocrinology

Metabolic abnormalities in patients with childhood onset of hypopituitarism – single center,long term observation

ea0070aep691 | Pituitary and Neuroendocrinology

Early basal growth hormone level and nadir growth hormone level in oral glucose tolerance test as predictors for surgical cure in acromegaly

ea0070aep692 | Pituitary and Neuroendocrinology

Quantitative bone assessment by radiofrequency echographic multi-spectrometry (REMS) in patients with acromegaly – a preliminary study

ea0070aep693 | Pituitary and Neuroendocrinology

Analysis of the value of bilateral inferior petrosal sinus sampling in the diagnosis and treatment of Cushing’s disease in patients with a negative or inconclusive result of magnetic resonance imaging

ea0070aep694 | Pituitary and Neuroendocrinology

Micromegaly or acromegaly? A retrospective longitudinal study on clinical aspects and comorbidities in a large cohort of patients referred to a single tertiary center

ea0070aep695 | Pituitary and Neuroendocrinology

Markers of recurrence in cushing’s disease: The role of post-operative serum cortisol and desmopressin test

ea0070aep696 | Pituitary and Neuroendocrinology

Long-term response to cabergoline treatment in men with macroprolactinoma is independent of tumor size

ea0070aep697 | Pituitary and Neuroendocrinology

Abstract unavailable

ea0070aep698 | Pituitary and Neuroendocrinology

Inferior petrosal sinus sampling – 16 years of experience from a single tertiary center in Israel

ea0070aep699 | Pituitary and Neuroendocrinology

Determinants of epicardial fat in patients with acromegaly

ea0070aep700 | Pituitary and Neuroendocrinology

Disconnection hyperprolactinaemia and its correlation with tumour size: A study of 210 patients with histologically proven non-functioning pituitary macroadenomas

ea0070aep701 | Pituitary and Neuroendocrinology

Role of 1 mg ACTH Stimulation Test to predict adrenocortical reserve and need of glucocorticoid therapy in non-functioning pituitary adenomas undergoing surgery

ea0070aep702 | Pituitary and Neuroendocrinology

Gigantism associated with hyperprolactinemia due to a pituitary macroadenoma in an adolescent girl

ea0070aep703 | Pituitary and Neuroendocrinology

Cabergoline resistance in a patient with prolactinoma with debut before puberty

ea0070aep704 | Pituitary and Neuroendocrinology

A rare etiology of hyperprolactinemia: Factitious hypoglycemia

ea0070aep705 | Pituitary and Neuroendocrinology

Pituitary gland metastasis of endometrial cancer: A case report

ea0070aep706 | Pituitary and Neuroendocrinology

Microprolactinoma, PCOS Or stress induced hyperprolactinemia? – case report

ea0070aep707 | Pituitary and Neuroendocrinology

A prolactinoma of rare localization as part of familial isolated pituitary adenomas

ea0070aep708 | Pituitary and Neuroendocrinology

A rare coexistence of acromegaly, myasthenia gravis, sicca syndrome, and elevated serum IgG4 levels: A single case report

ea0070aep709 | Pituitary and Neuroendocrinology

A case of cyclic cushing’s disease – cortisol surfing; catching the cortisol wave!

ea0070aep710 | Pituitary and Neuroendocrinology

Successful pregnancy in a woman with acromegaly treated with lanreotide

ea0070aep711 | Pituitary and Neuroendocrinology

Isolated adrenocorticotropic hormone deficiency in a female with ectopic posterior hypophysis

ea0070aep712 | Pituitary and Neuroendocrinology

Thickening of the pituitary stalk: About 4 cases

ea0070aep713 | Pituitary and Neuroendocrinology

Pregnancy and pituitary adenomas: A case series

ea0070aep714 | Pituitary and Neuroendocrinology

Short stature in turner syndrome: Should we assess growth hormone secretion?

ea0070aep715 | Pituitary and Neuroendocrinology

Case of differential diagnosis in a patient presenting with paroxysmal arterial hypertension

ea0070aep716 | Pituitary and Neuroendocrinology

A rare case of panhypopituitarism caused by TNF-α inhibitors

ea0070aep717 | Pituitary and Neuroendocrinology

Natural course of incidentally found nonfunctioning pituitary macroadenoma

ea0070aep718 | Pituitary and Neuroendocrinology

Evaluation of early predictors of metabolic syndrome in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NET)

ea0070aep719 | Pituitary and Neuroendocrinology

Experience in complex therapy of selective and non-selective dopamine agonists in women with resistant prolactinomas for recovering of ovulation function

ea0070aep720 | Pituitary and Neuroendocrinology

An analysis of craniopharyngioma patients in malta: Epidemiology, patient characterisation and long-term sequelae

ea0070aep721 | Pituitary and Neuroendocrinology

Septo-optic dysplasia with late-onset diagnosis: An uncommon presentation of a rare disease

ea0070aep722 | Pituitary and Neuroendocrinology

Doses of tolvaptan needed in chronic therapy of SIADH-induced euvolemic hyponatremia vary according to the etiology of SIADH

ea0070aep723 | Pituitary and Neuroendocrinology

Soluble alpha klotho measurement: Comparison of measurements by different commercially available assays in healthy subjects and active acromegaly

ea0070aep724 | Pituitary and Neuroendocrinology

Metformin and everolimus: A promising combination for neuroendocrine tumors treatment

ea0070aep725 | Pituitary and Neuroendocrinology

One year of growth hormone therapy in spanish adults with prader-willi syndrome (PWS) improves body composition without changes in bone mineral density

ea0070aep726 | Pituitary and Neuroendocrinology

Efficacy and safety of urea in syndrome of inappropriate secretion of antidiuretic hormone on a secondary hospital

ea0070aep727 | Pituitary and Neuroendocrinology

Multiple metastatic NET of unknown primary site in a young patient with carcinoid syndrome: Can we treat it as a gastrointestinal NET?

ea0070aep728 | Pituitary and Neuroendocrinology

A relationship between motilin and ghrelin in human motilin receptor transgenic mice

ea0070aep729 | Pituitary and Neuroendocrinology

Characterization of epithelial-mesenchymal transition in growth hormone-secreting adenomas

ea0070aep730 | Pituitary and Neuroendocrinology

Global methylation-demethylation status in pituitary neuroendocrine tumors as potential therapeutic target

ea0070aep731 | Pituitary and Neuroendocrinology

The expression of oxytocin receptor (OXTR) in metastatic pancreatic neuroendocrine tumors (PNETs)

ea0070aep732 | Pituitary and Neuroendocrinology

Metastatic insulinoma managed with lutetium (177LU) and somatostatin analog

ea0070aep733 | Pituitary and Neuroendocrinology

Tobacco smoke induces aberrant pulmonary neuroendocrine differentiation via different MAPK pathways

ea0070aep734 | Pituitary and Neuroendocrinology

Use of tolvaptan in acute post-surgical hyponatremia in patients with pituitary diseases

ea0070aep735 | Pituitary and Neuroendocrinology

Metabolic status of patients with combined pituitary hormone deficiency due to PROP1 mutation

ea0070aep736 | Pituitary and Neuroendocrinology

Kisspeptin levels in children and adolescents

ea0070aep737 | Pituitary and Neuroendocrinology

Body composition and bone mineral density in 107 patients with childhood onset growth hormone deficiency (CO-GHD) at the time of transition from pediatric to adulthood endocrine care

ea0070aep738 | Pituitary and Neuroendocrinology

Management of pregnant women with prolactinomas and analysis of their pregnancy outcomes

ea0070aep739 | Pituitary and Neuroendocrinology

Interleukin-6 response to insulin-induced hypoglycemia is associated with hypothalamic-pituitary-adrenal axis activation

ea0070aep740 | Pituitary and Neuroendocrinology

The effect of dual-release versus conventional hydrocortisone on fatigue, measured by ecological momentary assessments

ea0070aep741 | Pituitary and Neuroendocrinology

Cushing’s syndrome in the 21st century, not what it used to be: A single institution experience

ea0070aep742 | Pituitary and Neuroendocrinology

Visual impairment in patients with pituitary apoplexy

ea0070aep743 | Pituitary and Neuroendocrinology

Central hypothyroidism as an adverse effect of bexarotene treatment for cutaneous T-cell lymphoma

ea0070aep744 | Pituitary and Neuroendocrinology

Pasireotide-induced hyperglycemia and efficacy of antidiabetic treatments in patients with acromegaly: Evaluation of two referral centers

ea0070aep745 | Pituitary and Neuroendocrinology

The characteristic of patients with pituitary stalk lesions – single center,long term observation

ea0070aep746 | Pituitary and Neuroendocrinology

Preoperative pegvisomant as a potential therapeutic option to improve cardiac function in Acromegaly-induced cardiomyopathy: Two cases

ea0070aep747 | Pituitary and Neuroendocrinology

A prospective, non-interventional, observational, multi-center study of quality of life in people with acromegaly receiving lanreotide autogel

ea0070aep748 | Pituitary and Neuroendocrinology

Soluble klotho: A possible predictor of quality of life in acromegaly patients

ea0070aep749 | Pituitary and Neuroendocrinology

Pregnancy outcomes in women receiving growth hormone therapy enrolled in NordiNet international outcome study (IOS) and American Norditropin Studies: Web Enabled Research (ANSWER Program)

ea0070aep750 | Pituitary and Neuroendocrinology

Country-specific differences in adult growth hormone deficiency diagnosis and treatment rates

ea0070aep751 | Pituitary and Neuroendocrinology

Evaluation of haemolitic complement activity (ch50) and igg subclasses in adult growth hormone deficiency: Preliminary data

ea0070aep752 | Pituitary and Neuroendocrinology

FDG PET contribution to ectopic prolactinoma diagnosis - case report

ea0070aep753 | Pituitary and Neuroendocrinology

SF-12 or SF-36 in pituitary disease? towards concise patient-reported outcomes measurements

ea0070aep754 | Pituitary and Neuroendocrinology

The role of surgery in the treatment of craniopharyngioma: A comparison of the transsphenoidal approach and the interbasal hemisphere approach based on surgical outcomes

ea0070aep755 | Pituitary and Neuroendocrinology

An analysis of incidence and characteristics of cushing’s syndrome in malta: A population based study

ea0070aep756 | Pituitary and Neuroendocrinology

Patients receiving a range of doses of prior injectable somatostatin receptor ligands respond to oral octreotide in the treatment of acromegaly: Results from the phase 3 optimal study

ea0070aep757 | Pituitary and Neuroendocrinology

AIP gene germline mutations in non-selected patients with sporadic pituitary macrodenomas

ea0070aep758 | Pituitary and Neuroendocrinology

Silent corticotroph adenoma: Experience with six cases

ea0070aep759 | Pituitary and Neuroendocrinology

MRI follow-up of patients with acromegaly treated with first-generation somatostatin analogues (SMSa): Is there a difference during primary or post-operative treatment?

ea0070aep760 | Pituitary and Neuroendocrinology

Associations of endocrine and metabolic complications of childhood- and adult-onset craniopharingeoma with the histological subtype

ea0070aep761 | Pituitary and Neuroendocrinology

The united russian registry on patients with acromegaly

ea0070aep762 | Pituitary and Neuroendocrinology

Immunohistochemical subtypes of growth hormone-secreted pituitary adenoma and relationship with the clinical course and seconder malignancy

ea0070aep763 | Pituitary and Neuroendocrinology

Prolactinoma In childhood and adolescence – a systematic review and meta-analysis

ea0070aep764 | Pituitary and Neuroendocrinology

Combined pitutitary hormone deficiency in a patient with charge syndrome

ea0070aep765 | Pituitary and Neuroendocrinology

Controversies in the spectrum of GH-IGF-I axis disorders requiring replacement therapy

ea0070aep766 | Pituitary and Neuroendocrinology

Severe heart failure in a young male patient with unrecognized hypopituitarism consequent to hemorrhagic fever with renal syndrome and undiagnosed hemochromatosis

ea0070aep767 | Pituitary and Neuroendocrinology

Severe hyponatremia revealing hypopituitarism of undetermined etiology

ea0070aep768 | Pituitary and Neuroendocrinology

A case of isolated ACTH deficiency and autoimmune pancreatitis associated with pembrolizumab treatment

ea0070aep769 | Pituitary and Neuroendocrinology

Empty sella: Who thinks of it while studying hyponatremia?

ea0070aep770 | Pituitary and Neuroendocrinology

Massive pulmonary embolism in a newly diagnosed acromegaly patient

ea0070aep771 | Pituitary and Neuroendocrinology

Persistent hypercortisolism due to cushing disease

ea0070aep772 | Pituitary and Neuroendocrinology

The effect of chronic glucocorticoid exposure on brown adipose tissue in patients with cushing’s disease

ea0070aep773 | Pituitary and Neuroendocrinology

A rare outcome after surgical removal of insulinoma- case presentation

ea0070aep774 | Pituitary and Neuroendocrinology

Evaluation of factors associated with presence and growth of thyroid nodules in patients with acromegaly

ea0070aep775 | Pituitary and Neuroendocrinology

FSH levels are related to E-cadherin expression and subcellular location in non-functioning pituitary neuroendocrine tumours

ea0070aep776 | Pituitary and Neuroendocrinology

To optimize the acute octreotide suppression test in predicting the efficacy of long acting somatostatin analogues in acromegaly

ea0070aep777 | Pituitary and Neuroendocrinology

Acromegaly is associated with reduced socioeconomic status and more so in female patients: A nationwide population-based study

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Biosci Abstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more